Article Information
History
- September 7, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Limin Wang1,7,
- Julián Candia1,7,
- Lichun Ma1,7,
- Yongmei Zhao2,7,
- Luisa Imberti3,
- Alessandra Sottini3,
- Kerry Dobbs4,
- NIAID-NCI COVID Consortium,
- Andrea Lisco5,
- Irini Sereti5,
- Helen C. Su4,
- Luigi D. Notarangelo4,* and
- Xin Wei Wang1,6,*,8
- 1Laboratory of Human Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892
- 2CCR-SF Bioinformatics Group, Advanced Biomedical and Computational Sciences, Frederick National Laboratory for Cancer Research, 8560 Progress Drive, Frederick, Maryland 21701
- 3CREA Laboratory, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy
- 4Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
- 5Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892
- 6Liver Cancer Program, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892
- ↵*Correspondence: luigi.notarangelo2{at}nih.gov; xw3u{at}nih.gov
Posted September 07, 2020.
Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2
